Diffuse Large B-Cell Lymphoma: Using Immune Biomarkers to Define Novel Therapies

Hematological Oncology - United Kingdom
doi 10.1002/hon.121_2629
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley